Dr Naveen Bhadauria, Consultant Rheumatologist

Dr Naveen Bhadauria

Consultant Rheumatologist

Book online
|

Dr Naveen Bhadauria MBBS, MRCP, BSc Immunology

Consultant Rheumatologist

MBBS, MRCP, BSc Immunology

Dr Naveen Bhadauria

Consultant Rheumatologist MBBS, MRCP, BSc Immunology

MBBS, MRCP, BSc Immunology

Areas of expertise

  • Rheumatoid arthritis
  • Arthritis management plans
  • Crystal arthritis
  • Lupus
  • Multiple joint pains (polyarthralgia)

Address

About Dr Naveen Bhadauria

GMC number: 6104339

Year qualified: 2004

Place of primary qualification: University of London

Dr Naveen Bhadauria is a leading Consultant Rheumatologist and founder of Pure Rheumatology London, with private clinics based at The Shard (HCA UK) and One Welbeck.

He specialises in the rapid diagnosis and personalised treatment of arthritis, autoimmune disease, osteoporosis, gout, and a wide range of musculoskeletal and connective tissue conditions. Patients value his clear explanations, approachable manner, and commitment to providing the highest standards of care.

At Pure Rheumatology London, Dr Bhadauria has created a dedicated private service focused solely on rheumatology. The clinic offers state-of-the-art facilities, advanced investigations, and a full range of treatments, including joint and soft-tissue steroid injections and intravenous therapies such as zoledronate for osteoporosis.

Dr Bhadauria works closely with an expert multidisciplinary team — including orthopaedic surgeons, sports medicine consultants, and physiotherapists — to ensure patients benefit from a seamless, holistic approach to their care.

With short waiting times, rapid access to investigations, and central London locations, Pure Rheumatology London is committed to helping patients regain mobility, reduce pain, and improve quality of life.

Areas of Expertise:
• Arthritis (rheumatoid arthritis, osteoarthritis, psoriatic arthritis)
• Osteoporosis & bone health (including IV zoledronate infusion)
• Gout & crystal arthritis
• Connective tissue diseases (lupus, Sjögren’s, systemic sclerosis)
• Inflammatory back pain & ankylosing spondylitis
• Joint and soft-tissue steroid injections
• Autoimmune and systemic rheumatic diseases
• Corporate musculoskeletal & rheumatology health assessments

Treatments & Services:
• New patient rheumatology consultation
• Follow-up consultation
• Arthritis management plans
• Osteoporosis diagnosis & treatment (including IV infusion)
• Gout treatment & flare prevention
• Joint aspiration & injection procedures
• Soft-tissue injection procedures
• Blood tests, imaging & rapid diagnostics
• Personalised treatment plans for autoimmune conditions

Patient Care Philosophy
My approach is simple: I take the time to listen, explain clearly, and provide personalised treatment. Every patient deserves not just expert care, but reassurance, clarity, and confidence in their recovery.

Please visit https://privatelondonrheumatologist.com for further information.

Areas of expertise

  • Arthritis management plans
  • Autoimmune and systemic rheumatic diseases
  • Blood tests, imaging & rapid diagnostics
  • Connective tissue diseases (lupus, sjögren’s, systemic sclerosis)
  • Corporate musculoskeletal & rheumatology health assessments
  • Crystal arthritis
  • Gout treatment & flare prevention
  • Inflammatory back pain & ankylosing spondylitis
  • Joint and soft-tissue steroid injections
  • Joint aspiration & injection procedures
  • Lupus
  • Multiple joint pains (polyarthralgia)
  • Osteoporosis & bone health (including IV zoledronate infusion)
  • Osteoporosis diagnosis & treatment (including IV infusion)
  • Personalised treatment plans for autoimmune conditions
  • Rheumatoid arthritis
  • Soft-tissue injection procedures

Professional memberships

Royal College of Physicians
British Medical Association (BMA)
British Society for Rheumatology
General Medical Council

Articles by Dr Naveen Bhadauria

Olanzapine-Induced Rhabdomyolysis and Hyponatremia

A case of antisynthetase syndrome presenting solely with life-threatening interstitial lung disease

Drug-survival profiling of second-line biologic therapy in rheumatoid arthritis: Choice of another tumour necrosis factor inhibitor or a biologic of different mode of action?

Clinical aspects of Lyme disease